A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.
A new migraine medication, various generics, and more.
The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.
A novel bupivacaine formulation works as a 72-hour local anesthetic following shoulder surgery.
Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.
Subcutaneous injections of the new biologic, adalimumab-fkjp, were approved for seven indications.